Turn Therapeutics Inc. Reports Annual Proxy Filing and Market Activity
Turn Therapeutics Inc. (TTRX) closed the trading day on Tuesday, 20 October 2026, at USD 10.56, reflecting a 1.61 % increase over the preceding 24 hours. The stock remains highly liquid, with an available supply of 29.8 million shares and a market capitalization of USD 314.9 million. In the last 24 hours, approximately USD 321.1 thousand of TTRX shares were traded, a modest volume given the company’s overall market weight.
Proxy Statement and Upcoming Shareholder Meeting
On 19 October 2026, Turn Therapeutics filed its annual report and definitive proxy statement with the U.S. Securities and Exchange Commission (SEC). The documents provide a comprehensive overview of the company’s governance framework and outline key items to be considered at the forthcoming shareholders’ meeting. The meeting, scheduled for 30 November 2026, will be conducted online and will allow shareholders to vote on two principal matters:
- Election of Class I Directors – Two directors will be elected to represent the interests of the shareholders on the company’s board.
- Appointment of Independent Public‑Accountants – The election of WithumSmith+Brown, PC as the independent public‑accounting firm for the fiscal year ending 31 December 2026.
The proxy statement confirms Turn Therapeutics’ headquarters in Westlake Village, California, and notes that the company was formerly known as Global Health Solutions, Inc. Shareholders are encouraged to review the proxy documents on the SEC website and the company’s investor portal before the record date of 5 October 2026.
Recent Market Performance
Over the past 24 hours, TTRX traded up 1.61 %. In comparison, several peer stocks have exhibited varied performance:
| Ticker | Price Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|
| MVBF | –0.41 % | USD 29.01 | USD 377.5 M | 9.85 |
| CTEV | –0.72 % | USD 22.41 | USD 374.9 M | — |
| SLP | 0 % | USD 18.50 | USD 374.2 M | 46.22 |
| 6HV1.F | –8.21 % | USD 3.74 | USD 375.5 M | — |
| SI | +0.88 % | USD 18.50 | USD 376.6 M | — |
Notably, Claritev (CTEV) disclosed a change in beneficial ownership on 19 October 2026, with Jennifer Elizabeth Main acquiring a block of Class A shares through restricted stock units. Shoulder Innovations (SI) announced a board meeting on 19 October 2026 that reaffirmed executive appointments and adjusted senior director remuneration in line with SEBI listing requirements.
Technical Indicators
- Simple Moving Average (200‑day): USD 6.74
- 52‑Week High: USD 16.45 (18 September 2026)
- 52‑Week Low: USD 2.57 (20 November 2025)
Despite a 29.99 % decline since the end of the previous month, the stock’s recent rally suggests renewed investor confidence, potentially driven by the forthcoming proxy election and the company’s ongoing clinical development pipeline.
This article synthesizes publicly available data from the SEC filings and recent trading information. For detailed financial analysis, investors should consult the company’s official disclosures and independent market research.
